A Study on M2a Magnum Total Hip Arthroplasty
- Conditions
- Degenerative Joint DiseaseAvascular Necrosis
- Interventions
- Device: Total Hip Arthroplasty
- Registration Number
- NCT01010763
- Lead Sponsor
- Zimmer Biomet
- Brief Summary
The purpose of this study includes the investigation of Metal-ion release and Renal Function analysis in M2a Total Hip Arthroplasty.
- Detailed Description
There are no clinical studies conducted on its performance in Asian population. Furthermore clinical data is required to support marketing and validate design of M2A Magnum.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 184
- Patients suitable for primary Total Hip Replacement
- Patients aged over 20
- Patients with limited co-morbidity- ASA I-III
- Patients must be able to understand instructions and be willing to return for follow-up
- Patients willing to provide blood and urine samples for metal ion analysis at follow-up
- Pre-existing metal implants
- Infection, sepsis, and osteomyelitis
- Uncooperative patient or pt with neurologic disorders who are incapable of following directions
- Osteoporosis
- Metabolic disorders which may impair bone formation
- osteomalacia
- distant foci of infections which may spread to the implant site
- rapid joint destruction, marked bone loss or bone resorption apparent on roentgenogram
- vascular insufficiency, muscular atrophy, or neuromuscular disease
- pregnancy
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description M2a Magnum Total Hip Arthroplasty Total HIp Arthroplasty using with the M2a Magnum Large Metal Articulation is an ultra-high performance metal-on-metal articulation with a big ball (greater than or equal to 38mm) in acetabulums as small as 44mm. M2a Taper Total Hip Arthroplasty Total Hip Arthroplasty using with the M2a Taper Acetabular System consists of a titanium outer shell with cobalt chromium (Co-Cr-Mo) metallic liner, which articulates with with a cobalt chromium (Co-Cr-Mo) modular femoral head.
- Primary Outcome Measures
Name Time Method Range of Motion 1 year Hip Flexion Angle at 1 year postoperatively
- Secondary Outcome Measures
Name Time Method Metal Ion 5 year Blood Cobalt Ion Concentration 0 was imputed for the measurement result being below detection limit.
UCLA Activity Score 5 year UCLA is physician assessing scoring system to assess patient's activity level. Minimum score is 0 (completely inactive) and maximum score is 9 (Regularly participates in impact sports) with 1 point increments depending on patient's activity level.
Higher score means higher activity level achieved.Radiographic Assessment 5 year number of participants, whose x-ray shows any signs of radiographic changes (osteolysis, heterotopic ossification and/or radiolucency)
Harris Hip Score 5 year Harris Hip Score is physician assessing hip functional scoring system, which includes 4 components (pain, function, deformity and range of motion) with minimum score of 0 \& maximum score of 100.
Maximum \& Minimum score of each subscale is pain: 0-44, function: 0-47, Deformity: 0-4 and Range of motion: 0-5.
Current report uses summed score of each patient to compare total Harris Hip Score.
Higher score means better outcomes.
Trial Locations
- Locations (1)
Kansai Rosai Hospital
🇯🇵Amagasaki, Hyogo Pref., Japan